Immune cells’ intense reaction to the coronavirus may lead to pneumonia

The intense reaction of one of the lungs’ guardians against infection may help explain why COVID-19 can become severe.

The guardians, immune cells called interstitial macrophages, patrol lung tissue. These cells can be infected in a big way by SARS-CoV-2, researchers report online April 10 in the Journal of Experimental Medicine. Overwhelmed by the virus’ onslaught, the cells’ extreme inflammatory response may contribute to the development of pneumonia, a disease that damages the lungs and makes breathing difficult.

.email-conversion { border: 1px solid #ffcccb; color: white; margin-top: 50px; background-image: url(“/wp-content/themes/sciencenews/client/src/images/[email protected]”); padding: 20px; clear: both; } .zephr-payment-form-progress-bar.svelte-1be9qtg{width:100%;border:0;border-radius:20px;margin-top:10px}.zephr-payment-form-progress-bar.svelte-1be9qtg::-webkit-progress-bar{background-color:var(–zephr-color-background-tinted);border:0;border-radius:20px}.zephr-payment-form-progress-bar.svelte-1be9qtg::-webkit-progress-value{background-color:var(–zephr-color-text-tinted);border:0;border-radius:20px}.zephr-payment-progress-bar-step.svelte-1be9qtg{margin:auto;color:var(–zephr-color-text-tinted);font-size:12px;font-family:var(–zephr-typography-body-font),

→ Continue reading at Science News

More from author

Related posts

Advertisment

Latest posts

Can You Really Run on Top of a Train, Like in the Movies?

Just because you see something done in a movie, that doesn't mean you should try it yourself. Take, for example, a human running on...

Can’t pay or file your taxes by April 15? Here’s what happens if you miss Monday’s deadline | CNN Business

New York CNN  —  If you haven’t filed your 2023 tax return with the IRS yet and you still...

3 Affordable Pharma Stocks to Buy for Portfolio Gains

The pharmaceutical market is anticipated to grow substantially in the upcoming years, owing to technological innovation and rising demand for personalized medicines. To that...